US Begins First Human Embryonic Stem Cell Trial

US doctors have begun the first tests of human embryonic stem cells in patients, treating a man with spinal cord injuries in a landmark trial of the controversial process, the Geron Corporation said Monday.

The patient began the pioneering treatment Friday with an injection of the biotech company’s human embryonic stem cells, as part of a clinical trial that aims to test safety and efficacy toward regaining sensation and movement.

The treatment took place at the Shepherd Center in Atlanta, Georgia, a spokeswoman for the hospital told AFP, declining to give further details due to patient privacy concerns.

The Phase I trial is expected to involve around 10 patients. Participants in the human trials must be severely injured and start treatment with Geron’s product, GRNOPC1, seven to 14 days after sustaining their injury.

Patients will be given a single injection of two million of Geron’s GRNOPC1 cells in the trial.

Those taking part will be followed up for one year to monitor safety and also to see if they have regained any sensory function or movement in their lower extremities.

If the initial group of subjects shows no negative side-effects, Geron plans to seek FDA approval to extend the study to increase the dose of GRNOPC1 and to include patients with “as broad a range of severe spinal cord-injured patients as medically appropriate.”

The ultimate goal for GRNOPC1 is to inject it directly into the spinal cord lesions of injured humans where it would, Geron hopes, prompt damaged nerve cells to regrow, enabling patients to eventually recover feeling and movement.

Geron began working with human embryonic stem cells in 1999.

Back then, “many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials,” Geron’s president and chief executive Thomas Okarma said in a statement.

Okarma described Monday’s start of the clinical trial as “a milestone for the field of human embryonic stem cell-based therapies.”

GRNOPC1 is made up of cells containing precursors to oligodendrocytes — multi-tasking cells that occur in the nervous system.

Oligodendrocytes are lost in spinal cord injury, resulting in myelin and neuronal loss which cause paralysis in many patients.

Preclinical studies of GRNOPC1 found that when it was injected into the injury site of animals with spinal cord injuries, it migrated throughout the lesion site and matured into oligodendrocytes.

Those oligodendrocytes then re-lined axons with myelin, the insulating layers of cell membrane that wrap around the axons of neurons to enable them to conduct electrical impulses.

The process produced biologicals that enhance the survival and function of neurons, resulting in significantly improved locomotion in the treated animals.

In the animal trials, GRNOPC1 was injected seven days after the injury was sustained.

Every year, some 12,000 people in the United States sustain spinal cord injuries, usually in automobile accidents or from falls, gunshot wounds and sports.

Geron got clearance in January 2009 from the Food and Drug Administration to conduct human trials of GRNOPC1.

Around six weeks later, President Barack Obama reversed a ban on federal funding for research on human embryonic stem cells, which had been imposed by his predecessor at the White House, George W. Bush.

But the clinical trials of GRNOPC1 remained on hold for more than a year while the US courts wrangled about whether lifting the ban on embryonic stem cell research was legal.

Backers of the research believe the field holds huge potential for treating serious diseases including cancer and Alzheimer’s, and even for reversing paralysis.

Opponents argue that living embryos are destroyed in order to obtain the potentially life-saving embryonic stem cells.

Legislation passed by Congress in 1996 bans federal funding for research in which human embryos are either destroyed or discarded.

In lifting the ban on embryonic stem cell research, the Obama administration argued the research does not require disposal or destruction of the embryos, which were created for in-vitro fertilization treatments but never used.

Last month, a US appeals court ruled that the federal funding can continue, dissolving a lower court’s ban. Breitbart

Comments

  1. I ACTUALLY appeared to be pretty pleased to discover this web-site.I want to to thank you for your time for the wonderful learn!! I definitely enjoying any little it and I had you book-marked to see brand-new items you blog post.

  2. I simply appreciate this article completely, hope you could very well blog a great deal more in this particular.

  3. uk cardy ugg boots Its like you research my mind! You seem to find out so much about this, like you wrote the guide in it or something. I think which you can perform with some pics to generate the message home only a little bit, but other than that, that is great blog. uk cardy uggs on sale

  4. Nice post. I was checking continuously this blog and I am impressed! Extremely helpful information specially the last part I care for such information much. I was seeking this certain information for a very long time. I will keep the attention of your blog. Thank you and good luck.

  5. This can be an astonishingly astounding effective aid that you are presenting and you provide them away from costfree!! My partner and i which is like acquiring internet sites which normally understand the certain throughout providing you amazing understanding useful resource pertaining to no value. Most of us seriously quite a bit treasured inspecting this website. Enjoy it!

  6. Hey webmaster, commenters and everyone else !!! weblog was absolutely wonderful!

  7. Thank you for another magnificent article. Where else could anybody get that type of info in such an ideal way of writing? I’ve a presentation next week, and I am on the look for such info.

  8. You can certainly see your enthusiasm within the work you write. The sector hopes for even more passionate writers such as you who are not afraid to mention how they believe. All the time follow your heart.

  9. Hey, My personal thoughts on this material are that it’s well-written, intelligent and easy to understand. I appreciate this kind of useful information, especially when it is this good. In time your site will discover its potential. Thank you.

Trackbacks

  1. US Begins First Human Embryonic Stem Cell Trial : GuardiansPress…

    I found your entry interesting do I’ve added a Trackback to it on my weblog :)…